These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis. Chou YK, Edwards DM, Weinberg AD, Vandenbark AA, Kotzin BL, Fontenot AP, Burrows GG. J Immunol; 2005 Apr 01; 174(7):4316-24. PubMed ID: 15778396 [Abstract] [Full Text] [Related]
10. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells. Amicosante M, Berretta F, Franchi A, Rogliani P, Dotti C, Losi M, Dweik R, Saltini C. Eur Respir J; 2002 Nov 01; 20(5):1174-8. PubMed ID: 12449171 [Abstract] [Full Text] [Related]
11. Identification of multiple public TCR repertoires in chronic beryllium disease. Bowerman NA, Falta MT, Mack DG, Wehrmann F, Crawford F, Mroz MM, Maier LA, Kappler JW, Fontenot AP. J Immunol; 2014 May 15; 192(10):4571-80. PubMed ID: 24719461 [Abstract] [Full Text] [Related]
12. Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells. Amicosante M, Berretta F, Dweik R, Saltini C. Immunology; 2009 Sep 15; 128(1 Suppl):e462-70. PubMed ID: 19191908 [Abstract] [Full Text] [Related]
13. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma. Mandic M, Castelli F, Janjic B, Almunia C, Andrade P, Gillet D, Brusic V, Kirkwood JM, Maillere B, Zarour HM. J Immunol; 2005 Feb 01; 174(3):1751-9. PubMed ID: 15661941 [Abstract] [Full Text] [Related]
14. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, Saltini C, Sorrentino R, Lechler R. J Immunol; 2001 Mar 01; 166(5):3549-55. PubMed ID: 11207315 [Abstract] [Full Text] [Related]
15. Crystal structure of HLA-DP2 and implications for chronic beryllium disease. Dai S, Murphy GA, Crawford F, Mack DG, Falta MT, Marrack P, Kappler JW, Fontenot AP. Proc Natl Acad Sci U S A; 2010 Apr 20; 107(16):7425-30. PubMed ID: 20356827 [Abstract] [Full Text] [Related]
16. T cell recognition in chronic beryllium disease. Amicosante M, Fontenot AP. Clin Immunol; 2006 Nov 20; 121(2):134-43. PubMed ID: 16697706 [Abstract] [Full Text] [Related]
17. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP. Fontenot AP, Newman LS, Kotzin BL. Clin Immunol; 2001 Jul 20; 100(1):4-14. PubMed ID: 11414740 [No Abstract] [Full Text] [Related]